Day: June 13, 2025

Vancouver, BC, June 13, 2025 (GLOBE NEWSWIRE) — New Wave Holdings Corp. (“New Wave” or the “Company”) (CSE:NWAI, FWB:0XM0, OTCPK:TRMNF) is pleased to announce that it has made a strategic investment of US$150,000 into Cartwheel Robotics Inc. (“Cartwheel Robotics”). Founded in 2021, Cartwheel Robotics develops and builds advanced robotics products and provides engineering services to businesses looking to solve complex problems. Cartwheel Robotics’ interdisciplinary team has experience working on some of the most sophisticated and disruptive robotics platforms in the world. Cartwheel Robotics was founded and is led by Scott LaValley, who serves as the company’s Chief Executive Officer and Chief Technology Officer. Mr. LaValley brings extensive experience in robotics engineering and design from prominent companies, including Disney,...

ATLANTA, June 13, 2025 (GLOBE NEWSWIRE) — Chart Industries, Inc. (NYSE: GTLS) (“Chart”), a global leader in energy and industrial gas solutions, will present at the J.P. Morgan Energy, Power, Renewables & Mining Conference in New York. Jill Evanko, President and Chief Executive Officer will participate in a fireside discussion on Tuesday, June 24th, and a webcast is scheduled for 10:55 a.m. ET. A live audio webcast will be available on the company’s website at: Chart Industries, Inc. | News and Events – Events and Presentations and a replay of the webcast will be available following the conclusion of the event. About Chart Industries Chart Industries, Inc. is a global leader in the design, engineering, and manufacturing of process technologies and equipment for gas and liquid molecule handling for the Nexus of Clean™...

BOSTON, June 13, 2025 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that it will implement a 1-for-20 reverse stock split of its issued and outstanding shares of common stock (“Reverse Stock Split”), effective at 5:00 p.m. Eastern Time on June 16, 2025. The Reverse Stock Split was approved by the Company’s stockholders at the Company’s Annual Meeting of Stockholders held on May 21, 2025, with the final ratio subsequently determined by the Company’s Board of Directors. The reverse stock split is intended to bring the Company into compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market. The Company’s...

GAITHERSBURG, Md., June 13, 2025 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced an oral presentation and three poster presentations on pemvidutide at the American Diabetes Association’s (ADA) 85th Scientific Sessions, to be held in Chicago, IL from June 20-23, 2025. Pemvidutide is a novel, investigational GLP-1/glucagon dual receptor agonist under development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), obesity, alcohol use disorder (AUD) and alcohol-associated liver disease (ALD). Details for the oral presentation are as follows:Session Title: Early Phase, Post Hoc, and Subgroup Analyses from Clinical Trials Testing Incretin-Based Therapies –...

Frøya, 13 June 2025: Notice is given to the shareholders of Kaldvík AS that the Annual General Meeting will be held on 27 June 2025 at 12:00 hours (CEST). The meeting will be held digitally through Lumi AGM. Shareholders are encouraged to pre-register their attendance to the meeting and shareholders may also provide a proxy. Deadline for the pre-registration and registration of proxies is 25 June 2025 at 12:00 hours (CET). The notice for the Annual General Meeting, including the attendance and proxy forms, is attached to this announcement. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act For further information, please contact:Roy-Tore Rikardsen, CEO: +354 791 0006 (mobile)Robert Robertsson, CFO: +354 843 0086 (mobile)AttachmentWEB Kaldvik AS ...

– The International Society for Stem Cell Research (“ISSCR”) 2025 Annual Meeting is the world’s foremost gathering of stem cell and regenerative medicine leaders – – Updated data presented at ISSCR 2025 demonstrates >50% improvement in pain and function in a significant portion of cLDD subjects – – Number of evaluated subjects increases by more than two-fold since last update –– MELVILLE, N.Y., June 13, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative,” “BRTX” or the “Company”) (NASDAQ: BRTX), a clinical-stage regenerative medicine company developing stem cell-based therapies for serious musculoskeletal conditions, today announced the presentation of promising preliminary blinded data from the first 36 subjects in its ongoing Phase 2 clinical trial of BRTX-100, an autologous stem cell therapy for chronic...